Selçuk Ecza Deposu (SELEC) Fundamental Analysis

This page summarises the financial statements and the KapAI scorecard of Selçuk Ecza Deposu (SELEC) in the İlaç ve Sağlık sector for the 2026/6 period. Figures are compiled from the company’s reported balance sheet and income statement, in millions of Turkish lira.

Company Information

KapAI Scorecard

Overall score: 2.2 / 5

Summary Income Statement (TRY million)

Period: 2026/6 · Compared with: 2025/6

Item 2026/6 2025/6 Change
Revenue109,008100,201+8.8%
Gross Profit12,8027,857+62.9%
Operating Profit6,2261,029+505.2%
EBITDA00
Net Monetary Position Gains-3,165-2,899-9.2%
Net Profit for the Period2,182-422+617.4%

Summary Balance Sheet (TRY million)

Period: 2026/6 · Compared with: 2025/6

Item 2026/6 2025/6 Change
Current Assets87,68459,189+48.1%
Non-Current Assets14,05811,105+26.6%
Total Assets101,74270,294+44.7%
Current Liabilities62,95842,325+48.7%
Non-Current Liabilities1,6711,165+43.4%
Total Liabilities64,62943,490+48.6%